论文部分内容阅读
Background: Aneurysmal SAH remains a devastating disease with significant morbidity and mortality.To date,clinical variables are still used to evaluate injury severity and prognosis.This study was designed to investigate the role of CSF inflammasome proteins as laboratory-based biomarkers of brain injury severity and outcome in SAH patients.